SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000868278-24-000007
Filing Date
2024-05-10
Accepted
2024-05-10 16:04:58
Documents
66
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q prph-20240331.htm   iXBRL 10-Q 850767
2 EX-31.1 prph-20240331xexx3111.htm EX-31.1 10931
3 EX-31.2 prph-20240331xexx3121.htm EX-31.2 11092
4 EX-32.1 prph-20240331xexx3211.htm EX-32.1 5290
5 EX-32.2 prph-20240331xexx3221.htm EX-32.2 5480
  Complete submission text file 0000868278-24-000007.txt   5854584

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prph-20240331.xsd EX-101.SCH 45592
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prph-20240331_cal.xml EX-101.CAL 93302
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prph-20240331_def.xml EX-101.DEF 230744
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prph-20240331_lab.xml EX-101.LAB 600772
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prph-20240331_pre.xml EX-101.PRE 395698
70 EXTRACTED XBRL INSTANCE DOCUMENT prph-20240331_htm.xml XML 660688
Mailing Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530
Business Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530 (215) 345-0919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21617 | Film No.: 24934742
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)